Perimeter Solutions posts FY 2025 adjusted EBITDA of USD 331.7M, up 18% YoY

Reuters02-26
Perimeter Solutions posts FY 2025 adjusted EBITDA of USD 331.7M, up 18% YoY

Perimeter Solutions reported FY 2025 adjusted EBITDA of USD 331.7 million, up 18% YoY, according to its Q4 2025 earnings presentation. The company said it ended 2025 with net leverage of 1.1x (net debt to LTM adjusted EBITDA) and USD 325.9 million of cash and cash equivalents as of Dec. 31, 2025, with a USD 200 million revolving credit facility undrawn. As a corporate update, Perimeter said it acquired Medical Manufacturing Technologies, LLC $(MMT)$ in January 2026 for USD 685 million in cash. Perimeter said MMT generated about USD 140 million of revenue and USD 50 million of adjusted EBITDA on a full-year basis in 2025. The company also highlighted long-term assumptions including interest expense of about USD 75 million annually, tax-deductible D&A and other of about USD 60-65 million annually, and capital expenditures of about USD 30-40 million annually.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perimeter Solutions SA published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment